Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Spiny mice are better at regenerating hair after injury than laboratory mice and could help us understand how to improve human skin repair.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

A male with aromatase deficiency improved bone health with estradiol treatment.

Food deprivation increases MST enzyme in the brain, possibly affecting energy balance.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Men with testicular cancer were less likely to experience baldness and severe acne.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.